Targeting the interaction of Aurora kinases and SIRT1 mediated by Wnt signaling pathway in colorectal cancer: A critical review - 08/08/16
pages | 12 |
Iconographies | 8 |
Vidéos | 0 |
Autres | 0 |
Abstract |
The Aurora kinases belong to the family of serine/threonine kinase, a central regulator of mitosis and their expression increased during G2/M phase. It is classified into Aurora A, B and C, each has distinct roles in cellular processes, which includes regulation of spindle assembly, function of centrosomes, cytoskeleton and cytokinesis. During cancer growth, their rapid increase makes most attractive marker for cancer treatment at present. However Aurora A kinase is known to be a marker for cancer therapy, the most important serine/threonine kinase of Aurora B kinase involvement in cancer is still inadequate. Subsequently, the recent findings revealed that the class III histone deacetylase of SIRT1 is a key regulator to activate Aurora kinases from S phase damaged DNA through Wnt signaling pathway. Even if both Aurora A kinase and SIRT1 serve as a marker for cancer therapy, the present review reveals it is interaction in Wnt signaling pathway that solely for colorectal cancer.
Le texte complet de cet article est disponible en PDF.Abbreviations : AKAP, AML, APC, APC/C, ATM, ATR, BRCA1, CASP8, CBP, Cdc, Cdh1, CENP-A, Chk1/2, CK1α, CML, C-Nap1, CPEB, CRC, CSC, DAD, D-box, DLT, DNMT1, Drp1, Dsh, E2F, EB1, Eg5, Emi1, EMT, ESR1, FoxO, GADD45, GSK3β, GSTP1, HAT, HDAC, HIC1, hnRNP-k, Hsp, IGFII, INCEP, Ipl1, LRP 5/6, Mad2, MCAK, Mdm2, MTD, NAD+, Nek2A, Nlp1, Oct4, PBEF, PHA-739358, PI3K, Plk1, PP1, Ran-TPX2, Rb, Ret, Sox2, TCF/LEF, TPX2, Trk-A, VEGFR2, γ-TuRC
Keywords : Aurora kinases, SIRT1, Wnt signaling pathway and colorectal cancer
Plan
Vol 82
P. 413-424 - août 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?